• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Control of epidemic group A meningococcal meningitis in Nepal.

作者信息

Cochi S L, Markowitz L E, Joshi D D, Owens R C, Stenhouse D H, Regmi D N, Shrestha R P, Lacharya I, Manandhar M, Gurubacharya V L

出版信息

Int J Epidemiol. 1987 Mar;16(1):91-7. doi: 10.1093/ije/16.1.91.

DOI:10.1093/ije/16.1.91
PMID:3570627
Abstract

During the first six months of 1983, an epidemic of serogroup A meningococcal meningitis occurred in the Kathmandu valley of Nepal, resulting in 875 cases and 95 deaths. The annual attack rate was 103 cases per 100,000 population, with a peak attack rate occurring in April. Epidemic meningococcal disease had not been recognized previously in Nepal. Early in 1984, a review of hospital-based data on pyogenic meningitis in Kathmandu showed three times as many cases per month compared with the same period the previous year, suggesting that a recurrent epidemic was unfolding. Beginning in February 1984, a vaccination campaign directed at a high-risk target population of people aged 1-24 years was launched; over 329,000 doses of bivalent A/C meningococcal vaccine were given, achieving approximately 64% coverage of the target population. A dramatic decline in the number of new meningitis cases occurred coincident with the initiation of the mass vaccination campaign. This experience demonstrates that it is possible, with appropriate surveillance efforts, to detect an evolving epidemic of meningococcal disease early in its course and to institute control measures in advance of the expected epidemic peak.

摘要

相似文献

1
Control of epidemic group A meningococcal meningitis in Nepal.
Int J Epidemiol. 1987 Mar;16(1):91-7. doi: 10.1093/ije/16.1.91.
2
Epidemic meningococcal disease: recommendations for travelers to Nepal.流行性脑膜炎球菌病:对前往尼泊尔旅行者的建议。
MMWR Morb Mortal Wkly Rep. 1985 Mar 8;34(9):119-20, 125.
3
Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.加纳针对流行性脑膜炎的应急疫苗接种:对西非脑膜炎球菌病控制的影响
Lancet. 2000 Jan 1;355(9197):30-3. doi: 10.1016/S0140-6736(99)03366-8.
4
[An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].[1997年多哥萨瓦内地区的脑膜炎球菌性脑膜炎疫情:研究与控制策略]
Sante. 1997 Nov-Dec;7(6):384-90.
5
Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria.通过大规模疫苗接种控制流行性脑膜炎球菌性脑膜炎。I. 尼日利亚北部A群和C群疫苗的进一步流行病学评估。
J Infect. 1984 Sep;9(2):190-6. doi: 10.1016/s0163-4453(84)91429-4.
6
The 1990 meningococcal meningitis epidemic of Sarh (Chad): how useful was an earlier mass vaccination?
Acta Trop. 1995 Jun;59(3):211-22. doi: 10.1016/0001-706x(95)00081-o.
7
[Effect of 2 vaccination strategies on developments during the epidemic of meningococcal A meningitis in N'Djamena (Chad) in 1988].[1988年在恩贾梅纳(乍得)A群脑膜炎球菌性脑膜炎流行期间两种疫苗接种策略对疫情发展的影响]
Bull World Health Organ. 1993;71(3-4):311-5.
8
[Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].[1997年塞内加尔针对脑膜炎球菌性脑膜炎和黄热病开展大规模预防性免疫接种运动的微观经济评估]
Sante. 2003 Oct-Dec;13(4):215-23.
9
Impact of the meningococcal C conjugate vaccine in Spain: an epidemiological and microbiological decision.西班牙脑膜炎球菌C结合疫苗的影响:一项流行病学和微生物学决策。
Euro Surveill. 2004 Jul;9(7):11-5.
10
[Effectiveness of an immunization campaign with group A and C meningococcal polysaccharide vaccine in controlling an outbreak of group C meningococcal disease].A群和C群脑膜炎球菌多糖疫苗免疫接种活动在控制C群脑膜炎球菌病暴发中的效果
Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Jun;29(6):552-5.

引用本文的文献

1
Meningococcal disease in Asia: an under-recognized public health burden.亚洲的脑膜炎球菌病:一个被低估的公共卫生负担。
Epidemiol Infect. 2011 Jul;139(7):967-85. doi: 10.1017/S0950268811000574. Epub 2011 Apr 15.
2
Meningococcal disease and climate.脑膜炎球菌病与气候
Glob Health Action. 2009 Nov 11;2. doi: 10.3402/gha.v2i0.2061.
3
Review of the cost effectiveness of immunisation strategies for the control of epidemic meningococcal meningitis.控制流行性脑膜炎球菌性脑膜炎免疫策略的成本效益综述
Pharmacoeconomics. 2005;23(4):333-43. doi: 10.2165/00019053-200523040-00004.
4
Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.用于预防A群脑膜炎球菌性脑膜炎的多糖疫苗。
Cochrane Database Syst Rev. 2005 Jan 25;2005(1):CD001093. doi: 10.1002/14651858.CD001093.pub2.
5
Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses.A群脑膜炎奈瑟菌荚膜多糖O-乙酰化对功能性免疫反应发育的影响
Infect Immun. 2002 Jul;70(7):3707-13. doi: 10.1128/IAI.70.7.3707-3713.2002.
6
Meningococcal vaccines. Current status and future possibilities.脑膜炎球菌疫苗。现状与未来可能性。
Drugs. 1998 Mar;55(3):347-66. doi: 10.2165/00003495-199855030-00003.
7
Epidemiological investigation of an outbreak of meningococcal meningitis in Makkah (Mecca), Saudi Arabia, 1992.1992年沙特阿拉伯麦加流行性脑脊髓膜炎暴发的流行病学调查
Epidemiol Infect. 1995 Dec;115(3):399-409. doi: 10.1017/s0950268800058556.
8
Control of meningococcal epidemics.控制脑膜炎球菌性流行病。
Indian J Pediatr. 1987 Mar-Apr;54(2):131-4. doi: 10.1007/BF02750792.
9
Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination.自然感染或接种疫苗后人体对脑膜炎球菌外膜蛋白表位的免疫反应。
Infect Immun. 1989 May;57(5):1590-8. doi: 10.1128/iai.57.5.1590-1598.1989.
10
Characterization of epidemic and nonepidemic Neisseria meningitidis serogroup A strains from Sudan and Sweden.来自苏丹和瑞典的流行性和非流行性A群脑膜炎奈瑟菌菌株的特征分析。
J Clin Microbiol. 1990 Aug;28(8):1711-9. doi: 10.1128/jcm.28.8.1711-1719.1990.